These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 7515200)
1. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200 [TBL] [Abstract][Full Text] [Related]
2. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2. Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457 [TBL] [Abstract][Full Text] [Related]
3. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis. Brooimans RA; Van der Ark AA; Tomita M; Van Es LA; Daha MR Eur J Immunol; 1992 Mar; 22(3):791-7. PubMed ID: 1372260 [TBL] [Abstract][Full Text] [Related]
4. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation. Capey S; van den Berg CW Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772 [TBL] [Abstract][Full Text] [Related]
5. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells. Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. Rollins SA; Zhao J; Ninomiya H; Sims PJ J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395 [TBL] [Abstract][Full Text] [Related]
8. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608 [TBL] [Abstract][Full Text] [Related]
9. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Brooimans RA; van Wieringen PA; van Es LA; Daha MR Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224 [TBL] [Abstract][Full Text] [Related]
10. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells. Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195 [TBL] [Abstract][Full Text] [Related]
11. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAE hybrid, on complement-mediated swine endothelial cell lysis. Miyagawa S; Shirakura R; Iwata K; Nakata S; Matsumiya G; Izutani H; Matsuda H; Terado A; Matsumoto M; Nagasawa S Transplantation; 1994 Oct; 58(7):834-40. PubMed ID: 7524206 [TBL] [Abstract][Full Text] [Related]
12. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue. Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs. Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523 [TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395 [TBL] [Abstract][Full Text] [Related]
15. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor. Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845 [TBL] [Abstract][Full Text] [Related]
16. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. Rollins SA; Sims PJ J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum. Schmidt P; Goto M; Le Mauff B; Anegon I; Korsgren O Transplantation; 2003 Mar; 75(5):697-702. PubMed ID: 12640312 [TBL] [Abstract][Full Text] [Related]
18. Xenotransplantation: state of the art. Lavitrano M; Frati L Forum (Genova); 1999; 9(3 Suppl 3):74-83. PubMed ID: 10607850 [TBL] [Abstract][Full Text] [Related]
19. Characterization of rabbit complement component C8. Functional evidence for the species-selective recognition of C8 alpha by homologous restriction factor (CD59). White RV; Kaufman KM; Letson CS; Platteborze PL; Sodetz JM J Immunol; 1994 Mar; 152(5):2501-8. PubMed ID: 7510745 [TBL] [Abstract][Full Text] [Related]
20. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Hakulinen J; Meri S Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]